Expansion opportunities Fannin’s ongoing growth through investments and partnerships, including recent product launches (Morcellator, mAI Companion) and distribution deals, signals opportunities to cross-sell and expand into adjacent devices, diagnostics, and AI-enabled solutions across Ireland and the UK.

Strategic partnerships Active collaborations with manufacturers and distributors (Medovate SAFIRA, HPNE HPConnexx, MyBio) indicate a receptive market for distributed portfolios and co-branded initiatives; leverage these relationships to propose bundled offerings and regional growth strategies.

KOL and training demand Recent events like Morcellation Masterclass and clinical launches suggest a sustained need for education, training kits, and expert support; target hospital networks and training programs with value-added services and certified trainer packages.

Digital enablement Adopted tech stack (HubSpot, analytics, marketing automation) reflects readiness for targeted outreach, lead nurtures, and performance tracking; offer tailored digital campaigns, content marketing, and CRM-driven account plans to accelerate opportunities with mid-market healthcare facilities.

Geographic focus Island of Ireland presence with recent UK activities indicates potential to scale in cross-border markets; propose region-specific product launches, regulatory alignment support, and localized service agreements to capture institutional buyers across Ireland and beyond.